Sep. 19 at 10:31 AM
WATCHLIST SEP 19 2025
$NVO EMA's CHMP Adopted Positive Opinion For Kyinsu For The Treatment Of Adults With Type 2 Diabetes Insufficiently Controlled On Basal Insulin Or Glucagon-like Peptide 1 (GLP-1) Receptor Agonists
$BNAI BEN Appoints Dr. Ruy Carrasco to Board; Company to Debut Insurance AI Agent at Swiss Life Network Partners Conference in London
$JEF Jefferies And SMBC Group Expand Global Strategic Alliance With
$2.5B Credit Facilities, Joint Venture In Japan And Equity Ownership Increase
$MPTI M-tron Industries Awarded A Production Contract From A Top U.S. Department Of Defense Prime Contractor In Support Of A Brand New, Novel Multi-domain Data Link
$AMGN EMA's Human Medicines Committee Has Recommended Extending The Therapeutic Indication Of Uplizna To Include The Treatment Of Adult Patients With Active Immunoglobulin G4-related Disease